Sandra Cuellar
Chair IRB, University of Illinois Hospital & Health Sciences System
Contact
Address:
S. Wood street, Chicago, IL
Office Phone:
Email:
Related Sites:
About Heading link
Overview:
Sandra Cuellar, Pharm.D., BCOP, FHOPA, FASHP, is a Clinical Associate Professor in the Department of Pharmacy Practice at the University of Illinois at Chicago (UIC) College of Pharmacy. Dr. Cuellar has been active in the field of hematology/oncology for 20 years. She is the coordinator and clinical associate professor for oncology therapeutics. Dr. Cuellar received her Bachelor of Liberal Arts from Augustana College in Rock Island, Illinois, followed by her Pharm.D. degree from the University of Illinois at Chicago College of Pharmacy. She then completed a Pharmacy Practice Residency at University of Kentucky Chandler Medical Center. Following her residency, she completed a specialty oncology residency at MD Anderson Cancer Center in Houston, Texas. She currently is the clinical pharmacist in the Out-Patient Cancer Center, director of the oncology specialty residency program, and chair of IRB at UIC. Dr. Cuellar is an editor at large for Journal of Hematology Oncology Pharmacy and is involved in research, consulting and publications in the field of hematology/oncology. She has given multiple national and international presentations on cardio-oncology, supportive care, and oncology therapeutics. In addition, Dr. Cuellar serves as an ASHP oncology surveyor and leadership positions for the Hematology Oncology Pharmacy Association.
Teaching and Supervision Heading link
University of Malta, 4/11/2024 – 4/11/2024
Phar 509, 1/8/2024 – 5/8/2024
Spanish for Pharmacists (PMPR 337), 8/21/2023 – 11/30/2023
University of Malta, 4/17/2023 – 4/17/2023
PDAT 9: Hematology/Oncology (PHAR 509), 1/9/2023 – 4/28/2023
PDAT 9: Hematology/Oncology (PHAR 509), 1/9/2023 – 4/28/2023
PDAT 9: Hematology/Oncology (PHAR 509), 1/9/2023 – 4/28/2023
PDAT 9: Hematology/Oncology (PHAR 509), 1/9/2023 – 4/28/2023
PDAT 9: Hematology/Oncology (PHAR 509), 1/9/2023 – 4/28/2023
Selected Grants
Mobilizing for Patients Adherence to Cancer Therapies (mPACT), McKesson Fdn., 4/7/2014 - 9/30/2017, Obligated Amount: $250000; Anticipated Amount: $250000
Anemia Insights, Cetus Group LLC., 7/1/2005 - 9/15/2006, Obligated Amount: $6500; Anticipated Amount: $6500
Selected Publications
Kay Orbaugh, Kristi, MSN, Sandra, NP, Lisa, AOCNP, , Cuellar, , PharmD, , BCOP, , FHOPA, , FASHP, , Kennedy Sheldon, , PhD, , APRN-BC, , AOCNP, , FAAN, . (2024). How Can Oncology Nurses and Advanced Practice Providers Reduce the Burden of Chemotherapy-Induced Febrile Neutropenia in the US?. Journal of the Advanced Practitioner in Oncology, 15, (8). doi:10.6004/jadpro.2024.15.8.5.
Tichy, Eric M, Hoffman, James M, Tadrous, Mina, Rim, Matthew H, Cuellar, Sandra, Clark, John S, Newell, Mary Kate, Schumock, Glen T. (2024). National trends in prescription drug expenditures and projections for 2024. American Journal of Health-System Pharmacy, zxae105. doi:10.1093/ajhp/zxae105.
Tichy, Eric M, Hoffman, James M, Tadrous, Mina, Rim, Matthew H, Suda, Katie J, Cuellar, Sandra, Clark, John S, Newell, Mary Kate, Schumock, Glen T. (2023). National trends in prescription drug expenditures and projections for 2023.. American Journal of Health-System Pharmacy, 80, (14), 899-913. doi:10.1093/ajhp/zxad086.
Hellenbart, Erika, Cuellar, sandra. (2023). Updates in cardio-oncology. American College of Clinical Pharmacy Ambulatory Care Self-Assessment Program.
Cordes, Lisa, Cuellar, Sandra. (2023). Cancer Treatment and Chemotherapy. DiPiro’s Pharmacotherapy: a Pathophysiologic Approach, 12th Edition. McGraw-Hill Education / Medical.
Tichy, Eric M, Hoffman, James M, Suda, Katie J, Rim, Matthew H, Tadrous, Mina, Cuellar, Sandra, Clark, John S, Ward, Jennifer, Schumock, Glen T. (2022). National trends in prescription drug expenditures and projections for 2022. American Journal of Health-System Pharmacy, 79, (14), 1158-1172. doi:10.1093/ajhp/zxac102.
Desai, Alisha, Cuellar, Sandra. (2022). The Current Landscape for METex14 Skipping Mutations in Non–Small Cell Lung Cancer. Journal of the Advanced Practitioner in Oncology, 13, (5), 539-544. doi:10.6004/jadpro.2022.13.5.8.
Kamel, Josette, Meeder, Natalie, Cuellar, Sandra, Chan, David, Huber, Michael, Pasquinelli, Mary, Hulbert, Alicia, Khaddour, Karam, Feldman, Lawrence. (2021). Severe Psychiatric Symptoms in a Patient With EGFR Exon-20 Insertion Mutation Receiving Mobocertinib: A Case Report. JTO Clinical and Research Reports, 2, (11), 100241. doi:10.1016/j.jtocrr.2021.100241.
Tichy, Eric M, Hoffman, James M, Suda, Katie J, Rim, Matthew H, Tadrous, Mina, Cuellar, Sandra, Clark, John S, Wiest, Michelle D, Matusiak, Linda M, Schumock, Glen T. (2021). National trends in prescription drug expenditures and projections for 2021. American Journal of Health-System Pharmacy, 78, (14), 1294-1308. doi:10.1093/ajhp/zxab160.
Professional Leadership
Commission on Credentialing, American Society of Health-System Pharmacists, 8/15/2022 - 8/15/2025
Notable Honors
2023, PRN Practice Advancement Award, ACCP
2021, Fellow ASHP, American Society of Health-System Pharmacists
2021, Fellow of Hematology Oncology Pharmacy Association, HOPA
2017, UIC Recognition Team Patient Care, UI Health
2009, HOPA Literature Award, Hematology/Oncology Pharmacy Association
2005, Rho Chi Honor Society, The Rho Chi Society
Education
Degrees:
PharmD, University of Illinois at Chicago College of Pharmacy, USA, 2001
Postgraduate Training:
PGY-1, University of Kentucky Chandler Medical Center, USA, 2002
PGY-2, MD Anderson Cancer Center, USA, 2003
Licensures and Certifications
Board Certified Oncology Pharmacist, Board of Pharmacy Specialties, 2020 - 2026